Intralesional recombinant alpha 2a interferon therapy in superficial transitional cell carcinoma of the bladder

Eur J Cancer. 1991;27(10):1333. doi: 10.1016/0277-5379(91)90112-q.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Carcinoma, Transitional Cell / therapy*
  • Female
  • Humans
  • Injections, Intralesional
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Male
  • Middle Aged
  • Recombinant Proteins
  • Urinary Bladder Neoplasms / therapy*

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins